Bernarda Majc

Ljubljana, 1000, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study.

Trametinib-mediated MEK inhibition impairs cancer cell viability and invasion in patient-derived tumor avatars of glioblastoma with extraneural metastases: A proof-of-concept study.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 21, 2026

Glioblastoma-natural killer cell crosstalk: insights from dynamic spheroid models reveal the importance of secreted cytokines and the CD155 axis.

Glioblastoma-natural killer cell crosstalk: insights from dynamic spheroid models reveal the importance of secreted cytokines and the CD155 axis.

Journal: Cell communication and signaling : CCS

Published: October 29, 2025

Invasive properties of patient-derived glioblastoma cells after reversible electroporation in vitro.

Invasive properties of patient-derived glioblastoma cells after reversible electroporation in vitro.

Journal: Radiology and oncology

Published: August 11, 2025

The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression.

The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression.

Journal: Neuro-oncology advances

Published: February 18, 2025

New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases.

New Insights in ATP Synthesis as Therapeutic Target in Cancer and Angiogenic Ocular Diseases.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society

Published: May 11, 2024

Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma.

Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma.

Journal: iScience

Published: August 17, 2023

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.

Journal: Cancers

Published: December 07, 2022

The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling.

The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling.

Journal: Cancers

Published: October 25, 2022

Bioactive peptides from venoms against glioma progression.

Bioactive peptides from venoms against glioma progression.

Journal: Frontiers in oncology

Published: June 10, 2022

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors.

Journal: International journal of molecular sciences

Published: January 07, 2022

Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society

Published: July 26, 2021

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.

Journal: Molecules (Basel, Switzerland)

Published: July 06, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026